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Abstract
Background: Starting dialysis at an advanced age is a clinical challenge and an ethical dilemma. The advantages of
starting dialysis at “extreme” ages are questionable as high dialysis-related morbidity induces a reflection on the
cost- benefit ratio of this demanding and expensive treatment in a person that has a short life expectancy. Where
clinical advantages are doubtful, ethical analysis can help us reach decisions and find adapted solutions.
Case presentation: Mr. H is a ninety-year-old patient with end-stage kidney disease that is no longer manageable
with conservative care, in spite of optimal nutritional management, good blood pressure control and strict clinical
and metabolic evaluations; dialysis is the next step, but its morbidity is challenging. The case is analysed according
to principlism (beneficence, non-maleficence, justice and respect for autonomy).
In the setting of care, dialysis is available without restriction; therefore the principle of justice only partially applied,
in the absence of restraints on health-care expenditure. The final decision on whether or not to start dialysis rested
with Mr. H (respect for autonomy). However, his choice depended on the balance between beneficence and non-
maleficence. The advantages of dialysis in restoring metabolic equilibrium were clear, and the expected negative
effects of dialysis were therefore decisive. Mr. H has a contraindication to peritoneal dialysis (severe arthritis impairing
self-performance) and felt performing it with nursing help would be intrusive. Post dialysis fatigue, poor tolerance,
hypotension and intrusiveness in daily life of haemodialysis patients are closely linked to the classic thrice-weekly, four-
hour schedule. A personalized incremental dialysis approach, starting with one session per week, adapting the timing to
the patient’s daily life, can limit side effects and “dialysis shock”.
Conclusions: An individualized approach to complex decisions such as dialysis start can alter the delicate benefit/
side-effect balance, ultimately affecting the patient’s choice, and points to a narrative, tailor-made approach as an
alternative to therapeutic nihilism, in very old and fragile patients.
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“Dialysis should follow life,
not life dialysis”
Interview with Sonia Angelini,
on renal replacement therapy for over 30 years.
Background
Staring dialysis at an advanced age is not only a clinical
challenge but also an ethical one [1–4]. In fact, the
advantages of starting dialysis at “extreme” ages are
challenged by a growing body of data that show that,
in patients with high comorbidity, the benefits may
be offset by high dialysis-related morbidity, thus
impacting on quality of life, without an advantage for
survival [5–7].
Some authors have reported that with integrated clinical
management, including nutritional management and
optimization of symptomatic treatment, survival rates are
comparable to those obtained with dialysis [7–12]. This
option is often called “palliative care” or “conservative
care” and some authors maintain that it should be offered
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as an alternative to dialysis to fragile patients with “ter-
minal” end-stage renal disease (ESRD) [8–14]. The results
are not always easy to interpret, as the choice of palliative
care may be an indication of subtle fragilities or of a nihil-
ist, depressive attitude, both associated with lower sur-
vival. Within these limits, a recent meta-analysis found
equivalent one-year survival on palliative care and on
dialysis [14].
The contraposition between dialysis care and con-
servative care may however be less Manichean. Just
as the definition of alternative and complementary or
allied medicines has shifted from being opposed to
one another to being integrated, maximum “conserva-
tive care”, in its semeiotic meaning of “preserving the
residual kidney function” should probably be offered
to all patients, in particular to those with the highest
comorbidity [15–17]. Some groups, including ours,
have tried to graduate the dialysis indications accord-
ing to the individual’s clinical needs, in an effort to
progressively integrate the residual kidney function
and thereby ensure a smooth shift from pre-dialysis
to dialysis care [18–30].
In this report we will analyse a clinical case, referred
to as “Mr H”.
In addition to the analysis of its clinical issues, looking
at a case with an eye to the four principles of principlist
ethics, integrated when necessary with an individual
“narrative ethics” approach, can help clinicians decide
what to do and how to support patients in critical phases
of their disease.
Therefore, the case of Mr. H will be discussed on the
basis of the four principles, to exemplify how the modu-
lation of clinical options can change the beneficence/
non-maleficence balance, thus affecting ethical reasoning
and the patient’s choice [30–33]. Differently from other
recently reported cases, Mr. H received extensive coun-
selling, and all the options, including “non dialysis” were
thoroughly explained and examined; therefore we will
focus our discussion on how the way dialysis is done can
influence the decisional process [1, 2, 4].
Furthermore, we will discuss how combining princip-
lism with narrative ethics can furnish practical sugges-
tions, in the context of patient-centred, individualized
medicine [33–36].
Case presentation
The case we discuss is that of Mr. H, a 90-year-old
patient with end-stage kidney disease, diagnosed as
nephroangiosclerosis. This clinical diagnosis was based
on a long-standing history of hypertension, the presence
of diffuse signs of vascular disease, the absence of severe
proteinuria, relevant haematuria or systemic symptoms
suggesting a different cause of chronic kidney disease
(CKD). Furthermore, up to the last CKD phase, the
progression trajectory had been relatively slow, after
which a relatively rapid increase in creatinine was ob-
served in the course of 1 year (creatinine 1.52 mg/dl in
February 2007, 2.5 mg/dl in November 2015, 2.7 mg/dl
in January 2016, 3.1 mg/dl in March 2016).
In June 2016 Mr. H was hospitalised for a further
reduction in kidney function, probably after an oligo-
symptomatic infection (C-reactive protein 71 mg/l, fi-
brinogen: 7.44 g/l). At hospitalisation, serum creatinine
had reached 7.5 mg/dl, with severe acidosis (bicarbonate
15 mEq/l) and anaemia (haemoglobin 7.9 g/dl). The pos-
sibility of a cholesterol emboli syndrome was also con-
sidered, on account of the diffuse vascular disease
observed, but no eosinophilia, livedo reticularis or skin
lesions were present.
At hospitalisation, the patient’s weight was 80.7 kg, for
a body mass index of 30.7 Kg/m2 (height 1.62 m), with
no clinical signs of malnutrition; severe arthrosis and
diffuse leg hyperkeratosis were also part of the clinical
picture. During hospitalisation his general metabolic bal-
ance improved, but his serum creatinine stabilised be-
tween 6.0 and 7.0 mg/dL.
At 90 years of age, Mr. H lived alone, with help from
the social services for home management; he received a
hot meal at noon from a retirement home (in line with
the usual organization of French home support). The
meal served as a basis for lunch and supper, supple-
mented with bread, potatoes, or cheese. He kept a gar-
den and claimed to grow the best potatoes in the area.
While the usual prognostic indexes may not be of
great help in patients in advanced old age, his Charlson
index was 9 (high comorbidity, two-year survival prob-
ability of 30%), i.e. a comorbidity mainly linked to age
and end-stage kidney disease. Perhaps more importantly,
given the close link between nutritional status and sur-
vival, his SGA (subjective global assessment) score was
A (well nourished) and his MIS (malnutrition inflamma-
tion score) index was 3 (optimal).
With this background, the decision on whether or
not to start dialysis was discussed, including the
options of peritoneal dialysis, haemodialysis and a
low-protein diet. Since Mr. H suffered from severe ar-
throsis, which would have prevented self-performance,
and did not receive nursing care, it was decided that
peritoneal dialysis should not be undertaken. Haemo-
dialysis was considered as a potential option that
could be undertaken if absolutely necessary, and a
low-protein diet was chosen as the best initial option.
His diet was adapted to make up a 0.6–0.8 g/Kg/day
moderately restricted, plant-based, but not fully vegan,
low-protein diet that was supplemented with amino
and ketoacids (1 Ketosteril pill for each 10 Kg of
body weight), to avoid malnutrition. Given the low
probability of creating a functioning arteriovenous
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fistula, the placement of a tunnelled catheter was de-
cided on in case dialysis became necessary.
Close follow-up was started, with monthly or twice
monthly controls; however, acidosis was very difficult to
control and rapid unpredictable weight gain was ob-
served, requiring frequent hospitalisation, in spite of
good nutritional compliance, and good blood pressure
control.
From a theoretical point of view, treatment should
maximize survival and improve quality of life while the
negative effects produced should be minimal. This was
not fully clear in our patient and the medical and nurs-
ing staff was concerned about the clinical implications of
dialysis start in a patient of Mr. H’s age; therefore there
were further extensive discussions of treatment options,
presented by the nurses and a psychologist. After this
step, Mr. H, who had initially agreed to start dialysis was
reported to refuse treatment, considering it incompatible
with his daily routine. Subsequent conversations re-
vealed that the underlying problem was missing his mid-
day meal: “If I come to dialysis, I won’t be home at noon;
and if I’m not home at noon, the people who deliver my
meals will not find me, and if they do not deliver my
meals, I won’t have anything to eat. I’m 90, I have severe
arthrosis, and I’m no longer able to cook my meals my-
self. And I want to eat.”
Identification of the communication problem (presen-
tation of a standard haemodialysis technique of 4 hours
three times per week, instead of a tailored incremental
approach) led to an empiric “narrative” compromise,
with a prescription of 2.30–3.0 h of dialysis, one session
per week, combined with a 30-min change in the deliv-
ery time of his meals. Mr. H felt that this arrangement
was compatible with his needs.
At the time of the present report, Mr. H is alive and in
good clinical condition. He is still on a once-daily sched-
ule. Some relevant biochemical data are reported in
Table 1. They show good overall clinical and biochemical
stability, which would probably have been difficult to
achieve without treatment: even if the formulae for e-
GFR calculation are not precise in advanced old age,
9 mg/dL of serum creatinine corresponds to 5–6 mL/
min of GFR according to the formulae employed, and
the pre-dialysis level remains quite stable, thus suggest-
ing that we were not dealing with an acute and revers-
ible kidney injury on the basis of a chronic renal disease
(Table 1).
The main electrolytes are normal in the predialysis
phase, except for mild acidosis (Bicarbonate between 17
and 20 mEq/L); parathyroid hormone is in the 100–
300 ng/mL range and brain natriuretic peptide is be-
tween 80 and 120 pg/ml, in line with the absence of fluid
Table 1 Clinical and biochemical data before and after dialysis start
Predialysis (last biochemical data) 1 month of HD 6 months of HD 12 months of HD
Hospitalisations 23/06/2016 to 08/07/2016 none none none
08/08/2016 to 13/08/2016
03/10/2016 to 7/10/16
24/10/2016 to 01/11/2016 (dialysis
start)
Autonomy Preserved Preserved Preserved Preserved
Oedema (clinical) Yes No Weight loss on dialysis
0.5–1 kg
No Weight loss on dialysis
1–1.5 kg
No Weight loss on dialysis
0.5–1 kg
BP control Difficult (160–170/
90–100 mmHg)
OK (pre: 130–150/ 70–
90-mmHg)
OK (pre: 130–150/ 70–
90-mmHg)
OK (pre: 130–150/ 70–
90-mmHg)
BMI (Kg/m2) 31.7 33.09 33.29 33.71
BUN mg/dL 122.4 86.24 pre 96.88 pre 113.96 pre
34.72 post 41.16 post 50.68 post
Albumin g/dL 3.5 3.2 pre 3.6 pre 3.3 pre
3.3 post 4.0 post 3.6 post
Haemoglobin g/dL 13.4 11.5 11 11.1
Bicarbonate mmol/L 18 24 pre 27 pre 27 pre
26 post 28 post 22 post
Creatinine mg/dL 9.45 6.32 pre 5.71 pre 8.09 pre
3.05 post 3.35 post 3.72 post
BMI Body mass Index, BUN Blood Urea Nitrogen, BP Blood Pressure
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overload (little need for weight loss in dialysis, on fur-
osemide 120 mg/day). Haemoglobin has been kept on
target (10–11 g/l) with recombinant erythropoietin;
blood pressure has been controlled with Lercanidipine
20 mg, Nebivolol 5 mg and Urapidil 120 mg. Serum al-
bumin is well preserved, and the patient’s “dry weight”
increased after the start of dialysis. Mr. H is still on a 0.8 g
of protein/Kg/day diet, supplemented with Ketosteril
(1 each 10 Kg of BW).
Meanwhile, he has celebrated his ninety-first birthday.
His good clinical and psychological adaptation to dialysis
treatment have made the medical and nursing group
confident that it will be possible to extend this option to
a twice weekly schedule, with limited dialysis time (2.5–
3 h) if necessary in the future.
The principlist approach
In this first part of the discussion we analyse the case of
our ninety-year-old patient on the basis of the four prin-
ciples of justice, autonomy, beneficence and non-
maleficence, as an integration to the clinical discussion
and as a way to highlight the points in which a flexible
clinical approach, in line with personalized medicine,
can support a patient’s decisions.
Justice
There are several ways to consider justice from an eth-
ical point of view in medicine; although they are all legit-
imate, they differ markedly [37–44].
A “social” reading of justice sees it as the fair distribu-
tion of opportunities and resources between individuals,
with particular attention to competing situations, in
which the choice of care for one patient may mean a
lack of availability of care for another [38–44].
Since in the setting of in which Mr. H received care
(France) dialysis treatment is available without limita-
tion for all patients needing it, we considered that he
had the right to be treated. While the risk of over-
treating and of a futile use of resources persists, our
patient is not the only nonagenarian on dialysis, nor
the oldest one reported in the literature, in which
positive results have been recorded, challenging an
age-centred policy [45–48].
On a more general basis, our case elicits somewhat
contrasting reflections on the complex relationship be-
tween physicians’ time, delivery of resources and the
cost efficiency of health care services. In this context,
justice may have a more pragmatic connotation. In set-
tings of limited resources, in which dialysis treatment is
not freely available, or is limited by logistic reasons, a
lower number of dialysis sessions per patient makes it
possible to treat more individuals, and optimise access
to care. In contrast, in high-resource settings, in which
dialysis is a well-established right, and often a quite cost-
efficient treatment, a flexible approach to dialysis ses-
sions is a departure from a rigid “thrice-weekly” organ-
isation, thus reducing the economic efficiency of the
system. A tailor-made dialysis system is, of course, not
incompatible with economic efficiency, but as a rule,
flexibility and cost-cutting are inversely related, and
treatments that differ from a time-honoured routine
usually require additional control, which is obviously
more demanding.
In this regard, personalized medicine, increasingly ad-
vocated as the best model of care, emphasizes the ethical
issues physicians face: is their primary responsibility to
guarantee the individual patient’s rights, or to ensure the
economic efficiency of the health care system?
On an organizational basis, we need to take into
account that personalization requires medical time, as
does discussion; while the temptation to dismiss this
issue by arguing that “time constraints make it impos-
sible to follow all patients in this way” is evident, person-
alized medicine offers a precious tool not only for
defending the autonomy of physicians’ choices, but also
for ensuring that time is available for attaining this
qualitative goal.
A “legal” interpretation of the sense of justice sees it as
synonymous with laws. In this context, Mr. H’s right to
treatment is guaranteed by French law, as is his decision
not to undertake dialysis treatment if he does not wish
to [49].
In addition, justice can be seen as a moral/ethical
right, taking religious beliefs into account. In this regard,
Mr. H’s religious beliefs may have influenced his deci-
sion on whether or not to undertake a potentially com-
plex treatment, but once more, the decision was his, and
offering dialysis to an elderly, independent and compe-
tent person does not challenge current ethical or moral
norms [50–53].
Respect for autonomy
In western countries, respect for the patient’s autonomy
is usually considered to be the most important of the
four principles, which is of particular importance when
different principles are in conflict or are not syntonic, as
in the case of Mr. H, in which the balance between benefi-
cence and non-maleficence is particularly delicate [54, 55].
In fact, in the absence of an a priori decision in favour
or against starting dialysis, the choice Mr. H. made
depended on how he saw the balance between benefi-
cence and non-maleficence, the latter consisting in the
risks and side effects involved in dialysis.
A discussion of the impossibility of offering patients
wholly unbiased information, as it is inevitable that phy-
sicians’ or nurses’ convictions will influence how they ex-
plain options to patients, and of the role of the “way we
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say” things, whose importance sometimes overrides the
meaning of the content, is beyond the scope of this
paper [56–58].
Information depends upon the model of care: pater-
nalistic approaches “manoeuvre” patients towards the
physician’s opinions, and can be considered intrusive,
while a purely informative model often lacks empathy
and participation [57–65]. Personalizing medical care
goes along with a holistic approach and with an individ-
ual patient-physician relationship. This model involves
presenting information honestly but not necessarily im-
partially, an approach in which personal opinions are
mitigated, discussed and critically reviewed. In this
regard, the physician counsellor’s role is to facilitate the
expression of the patient’s opinions, within an empathic
relationship [66–72].
By definition, empathy cannot exist without pathos,
nor can counselling without convictions.
In the case of Mr. H, we chose the dynamic inter-
action of therapeutic alliance: in this model, the phys-
ician not only offers a choice of all the feasible options
(in this case, starting dialysis or continuing with support-
ive treatment), but discusses with the patient how to
adapt the options to their needs and preferences. When
using this model, the strategy chosen may be a com-
promise between the “best”, or most validated option,
and a reasonable, but more feasible one.
In the case of incremental dialysis, there is wide
variability between specific modalities: while some au-
thors hold that dialysis should be started with “soft”
once-weekly sessions, others prefer a longer session,
or define twice-weekly dialysis as incremental. In the
absence of a validated, uniform way to perform this
schedule, we adapted the initial policy to the patient’s
needs and concerns (being home to receive meals).
While in his case the initial policy proved to be suc-
cessful and the original schedule was followed for 1
year, the same dynamic approach could have been
followed if additional adaptations or changes had
been needed.
A further issue, that here is mentioned only in passing,
on account of its extreme complexity, is the feasibility of
a non-experiential choice in the exquisitely subjective
field of “tolerance”, in which an individual’s response is
nearly impossible to foresee a priori.
In this regard, a shared decision process also sup-
ports starting dialysis on a “trial basis”, to test tole-
rance, and clinical advantages; no approach is without
cost, but since the patient (see Table 1) had fre-
quently been hospitalised, and was in an unstable
metabolic balance, we considered that the risks of a
dialysis trial (tunnelled catheter and dialysis start)
were balanced by the expected benefit of improved
metabolic stability.
The further implications regarding the beneficence/
non-maleficence balance will be discussed below.
Beneficence
The potential benefit of correcting the most troublesome
metabolic derangements of severe CKD is obvious. In
the case of Mr. H, whose glomerular filtration rate was
around 5 mL/min, the presence of severe acidosis and
the difficulty involved in managing the delicate balance
between dehydration and fluid overload, were clear indi-
cations of the need for dialysis start.
Furthermore, while recent data challenge the policy of
starting dialysis on the sole basis of a decreased glom-
erular filtration rate, whose reliability is uncertain in eld-
erly patients, there is no doubt that dialysis can be
successful in octogenarians and nonagenarians, espe-
cially if adapted to the needs and problems of this fragile
population [73–76].
As will be further discussed, the problem may not be
starting dialysis, but which dialysis should be started to
maximize benefits, considering the patient’s age and life
expectancy.
The potential relationship between dialysis schedule,
beneficence, and non-maleficence will be discussed in
detail in the next section.
Non-maleficence
Dialysis is a prison: this harsh statement, recently pub-
lished in a widely-read French newspaper, reflects the
common opinion of this life-saving treatment [77].
There are several reasons why this statement may apply
to dialysis patients; however, at least some of the often-
cited tortures dialysis entails can be mitigated by a per-
sonalized schedule of incremental treatment.
In particular, post-dialysis fatigue is closely related to
intradialytic shifts and intradialytic weight loss. The
experience with short daily dialysis sessions shows that a
shorter session is usually better tolerated, with an signifi-
cant reduction in post-dialysis fatigue [18–25, 78–82].
If dialysis is highly intrusive in daily life, this is obvi-
ously also related to the number of sessions per week.
While there is still no agreement on the definition of
“incremental” dialysis, some U.S. experts presently
suggest an approach based on twice-weekly dialysis
[18, 19, 83–85]. In Italy, where it is often part of an
integrated approach which includes nutritional man-
agement, dialysis start generally involves one session
per week, while continuing the diet prescribed in the
pre-dialysis phase (usually with a moderate protein re-
striction, at 0.6–0.8 g/Kg/day) [18–29, 86]. As Mr. H
was correctly following a low-protein diet, to minimize
the risk of malnutrition, we chose this second option
for starting dialysis.
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The slow progression of his chronic kidney disease,
with good residual diuresis and lack of life-threatening
episodes of ionic derangements (including hyperkalemia)
further supported this approach [85–89].
No less importantly, as previously mentioned, an in-
cremental dialysis start allowed us to perform a “dialysis
test” for tolerance, and reach an experience-based deci-
sion on whether dialysis treatment should be continued,
intensified or discontinued.
In our case we believe that the “treatment test” was
the best way to overcome a potentially endless discus-
sion on the advantages versus the drawbacks of the in-
cremental dialysis policy that we had a priori identified
as a clinically reasonable choice, in keeping with Mr. H’s
everyday routine and quality of life.
In fact, a single 3-h dialysis session per week might
not correct fluid overload or acidosis; instead a moder-
ately protein-restricted diet (which had been prescribed
in the pre-dialysis phase, and had been compatible with
preserved nutritional status) could induce malnutrition.
Furthermore the presence of a vascular access, or the
development of intradialytic or post-dialysis hypotension
could have had a negative effect on quality of life and
morbidity.
The biological variability of the “old-old” is well
known, and, although several experiences of incre-
mental dialysis have been published, the data are still
too scant to supply exhaustive indications (nutritional
approach in well-nourished 90-year-old patient previ-
ously on a low-protein diet).
The good results obtained in our patient, apparently
thanks to the combined benefits of diet and dialysis,
cannot of course be taken as an a posteriori demonstra-
tion of the efficacy of this policy; conversely, they do
suggest that being flexible and adapting to the patient’s
needs means that an approach can be evaluated and
adjusted as treatment progresses.
The narrative analysis
While principlist ethics offer a simple framework for
analysing the clinical problem, a narrative approach en-
ables us to identify solutions in individual cases, taking
into account the patient’s history, family support, fears
and concerns, as well as daily life routine [33–35].
By definition, a narrativist tries to capture the stories
that patients and their families tell or hide, and that, with
silences as well as words, characterize decision-making
[33]. Narrativism brings flexibility and personalization into
the discussion and helps mitigate rigid reasoning based on
the four principles, by introducing inventive solutions and
practical strategies, such as changing the time of meal
delivery, or scheduling dialysis sessions early to allow Mr.
H to be home in time for lunch [90–92]. Furthermore, a
narrative approach seeks to identify the fears or problems
behind the facts, in this case, Mr. H’s fear of changing the
rhythm of his daily life and losing autonomy.
The history of our patient reflects the need for a flex-
ible approach adapted to his needs that takes into con-
sideration the importance different individuals attribute
to the constraints of daily life. A problem with the home
delivery of hot meals may seem trivial in comparison to
living or dying, but can appear as unsolvable to an eld-
erly individual, becoming the focus of their fears and
concerns. In this regard, finding pragmatic solutions is
not only a way to come to grips with a specific incon-
venience, but also shows the patient that problems can
be solved and dialysis can be adapted to their needs and
wishes, and need not be “a prison”.
Combining principlism and narrative analysis
In terms of a principlist analysis, it seemed likely that
Mr. H would benefit from a flexible approach to dialysis,
which would serve to overcome his health problems
(benefit: clinical stabilisation in the context of a uremic
syndrome with difficulty in attaining a stable clinical bal-
ance with non-dialytic conservative care). Attention to
minimizing side effects (non-maleficence) led to the
choice of an incremental dialysis approach, in a setting
in which the principle of justice was respected, at least
for treatment availability (no competition with other pa-
tients who also needed dialysis). While the physicians
were mainly concerned with finding the best comprom-
ise between beneficence and non-maleficence, the pa-
tient was worried about the disruption of his daily
routine (home-delivered meals). While he was not a
priori against dialysis (he had initially accepted it), he
subsequently refused treatment because “If I’m not
home… I won’t have anything to eat”.
A rigid interpretation of autonomy would probably
have led to his not starting dialysis (the patient was in-
formed, competent, and free to choose); inquiring in de-
tail about what had made him change his mind, and
asking about his habits and quality of life, identified a
problem (missing meal delivery) and found pragmatic
solutions that did not impact on clinical aspects, but
modulated the individual’s choice (autonomy). Narrati-
vism allowed us to get a detailed picture of the patient
and mitigated the rigidity of the four principles; while
many of the considerations regarding dialysis start could
apply to other elderly patients with end-stage kidney dis-
ease, the patient’s choice was unique to Mr. H, as the so-
lution also was.
In this regard, we suggest that principlism allows us to
arrive at an initial analysis of difficult cases, identifying
the specific aspects of the problems involved, while nar-
ration serves to put problems in perspective and possibly
solve them.
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Discussion and conclusions
The case discussed illustrates the limits of a Manichean
contraposition between dialysis and palliative care.
In this extreme balance, dialysis is intended as “renal
replacement therapy” (RRT), a treatment that has to de-
liver, regardless of the residual renal function, full artifi-
cial depuration. While the definition of “adequate” and
“optimal” dialysis is not clear, a strict “RRT approach” ig-
nores residual renal function, in spite of the fact that its
presence is one of the most important survival markers
[18, 25–27, 87–89].
Palliative-conservative care is defined as a comprehen-
sive treatment which allows for reasonable survival, with
a good quality of life, without dialysis [10–14]. However,
it is not clear why we should not offer this to all pa-
tients, and start dialysis only when an acceptable clinical
balance can no longer be maintained using conservative
treatment.
Indeed, this sharp opposition between palliative-
conservative care and dialysis, which is often thought to
be unavoidable, has begun to be seen as less of a con-
trast, and what is now being proposed is the integration
of the two in what is called kidney supportive care,
aimed at improving the quality of life, whenever possible
together with therapies intended to prolong life, such as
dialysis. Furthermore, the term palliative dialysis is also
occasionally used to indicate a form of patient-centered
dialysis that focuses on quality of life.
In our case, the decision to start dialysis was post-
poned until the time when “conservative care” could no
longer ensure well-being. The once-weekly session was
started to correct acidosis, reduce overload, and allow
some degree of correction of uremic intoxication. The
interventions were graduated to clinical context and life
expectancy, and their purpose was to correct the de-
rangements associated with short-term clinical problems
(acidosis and overload).
The contraposition between RRT and palliative-
conservative care points to what is now called “transi-
tion” to dialysis [11–14]. Studies on the high risk of
death during the first months of dialysis deal with an
abrupt transition from pre-dialysis care to thrice weekly
4-h haemodialysis sessions (or to a “full” schedule on
peritoneal dialysis).
The choice of starting a “full schedule” of dialysis is
often the only one possible in patients with minimal or
no predialysis follow-up that start dialysis when admit-
ted to the emergency room. However, in patients who
have been consistently followed, the best choice may be
to progressively increase their scheduled visits, from
every 3 months to once a month to weekly, to a once-
weekly dialysis sessions.
The case of Mr. H, in which the availability of a “soft”
dialysis start smoothed the terms of a tough ethical
dilemma, without forcing us to sacrifice quality to quan-
tity of life, is a story with a happy ending, at least for the
time being: our patient is doing well on dialysis, enjoys
his role as our “oldest patient”, gets home by the time
his meal is delivered, and tolerates dialysis sessions well.
Concerned about his daily routine, Mr. H would not
have accepted more intrusive treatment which, as his
story shows, was not really needed; his positive experi-
ence with dialysis will modulate his further choices, in-
cluding intensifying dialysis, if need be.
In conclusion, this case encourages us to reflect on the
reasons why laypeople and many physicians have a nega-
tive view of dialysis. Is dialysis in itself a killer, or is the
way we use this treatment the cause of “dialysis shock”?
Unlike standardized medicine, based on identifying the
best solution, in an ethical discussion there is no best so-
lution, but instead a personalized choice adapted to the
context and to the individual. As in chemotherapy, in
which protocols are increasingly being adapted to pa-
tients, there is room and a need for well-grounded “per-
sonalized medicine” in renal replacement therapy.
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